Citation: | Lian Qiaoyan, Chen Ao, Xu Xin, et al. Analysis on dynamic changes of T lymphocyte subsets in recipients with stable graft status after lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 83-89. doi: 10.3969/j.issn.1674-7445.2021.01.013 |
[1] |
HSIAO HM, SCOZZI D, GAUTHIER JM, et al. Mechanisms of graft rejection after lung transplantation[J]. Curr Opin Organ Transplant, 2017, 22(1):29-35. DOI: 10.1097/MOT.0000000000000371.
|
[2] |
练巧燕, 陈奥, 巨春蓉.肺移植术后T细胞亚群研究进展[J/CD].中华移植杂志(电子版), 2019, 13(2): 151-155. DOI: 10.3877/cma.j.issn.1674-3903.2019.02.016.
LIAN QY, CHEN A, JU CR. Progress on T lymphocyte subsets after lung transplantation[J/CD]. Chin J Transplant (Electr Vers), 2019, 13(2): 151-155. DOI: 10.3877/cma.j.issn.1674-3903.2019.02.016.
|
[3] |
CALAROTA SA, CHIESA A, DE SILVESTRI A, et al. T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation[J]. J Clin Virol, 2015, 69:110-116. DOI: 10.1016/j.jcv.2015.06.078.
|
[4] |
SNELL GI, YUSEN RD, WEILL D, et al. Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading-a 2016 consensus group statement of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2017, 36(10):1097-1103. DOI: 10.1016/j.healun.2017.07.021.
|
[5] |
COSIMI AB, COLVIN RB, BURTON RC, et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts[J]. N Engl J Med, 1981, 305(6):308-314. DOI: 10.1056/NEJM198108063050603.
|
[6] |
YAMADA Y, BRÜSTLE K, JUNGRAITHMAYR W. T helper cell subsets in experimental lung allograft rejection[J]. J Surg Res, 2019, 233:74-81. DOI: 10.1016/j.jss.2018.07.073.
|
[7] |
LIU Z, FAN H, JIANG S. CD4(+) T-cell subsets in transplantation[J]. Immunol Rev, 2013, 252(1):183-191. DOI: 10.1111/imr.12038.
|
[8] |
马锡慧, 高钰, 韩永, 等.流式细胞术在肾移植术后感染中的诊断价值[J].器官移植, 2018, 9(2):137-141, 155. DOI: 10.3969/j.issn.1674-7445.2018.02.008.
MA XH, GAO Y, HAN Y, et al. Diagnostic value of flow cytometry in postoperative infection after renal transplantation[J]. Organ Transplant, 2018, 9(2):137-141, 155. DOI: 10.3969/j.issn.1674-7445.2018.02.008.
|
[9] |
CALAROTA SA, ZELINI P, DE SILVESTRI A, et al. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients[J]. Transplantation, 2012, 93(1):112-119. DOI: 10.1097/TP.0b013e318239e90c.
|
[10] |
GARDINER BJ, NIERENBERG NE, CHOW JK, et al. Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients[J]. Clin Infect Dis, 2018, 67(9):1395-1402. DOI: 10.1093/cid/ciy295.
|
[11] |
IOVINO L, TADDEI R, BINDI ML, et al. Clinical use of an immune monitoring panel in liver transplant recipients: a prospective, observational study[J]. Transpl Immunol, 2019, 52:45-52. DOI: 10.1016/j.trim.2018.11.001.
|
[12] |
LEE SD, KIM SH, KONG SY, et al. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab[J]. Transpl Immunol, 2015, 32(1):29-34. DOI: 10.1016/j.trim.2014.11.216.
|
[13] |
SHAH RJ, DIAMOND JM. Update in chronic lung allograft dysfunction[J]. Clin Chest Med, 2017, 38(4):677-692. DOI: 10.1016/j.ccm.2017.07.009.
|
[14] |
KUMAR R, ISON MG. Opportunistic infections in transplant patients[J]. Infect Dis Clin North Am, 2019, 33(4):1143-1157. DOI: 10.1016/j.idc.2019.05.008.
|
[15] |
纪勇, 陈静瑜, 郑明峰, 等.肺移植术后早期原发性移植物失功的危险因素与防治[J].中华胸心血管外科杂志, 2017, 33(12):738-742. DOI: 10.3760/cma.j.issn. 1001-4497.2017.12.009.
JI Y, CHEN JY, ZHENG MF, et al. Clinical analysis of risk factors for early primary graft dysfunction after lung transplantation[J]. Chin J Thorac Cardiovasc Surg, 2017, 33(12):738-742. DOI: 10.3760/cma.j.issn.1001-4497.2017.12.009.
|
[16] |
钟元, 孟礼飞, 杨旭晖, 等.肺移植免疫抑制剂的应用进展[J].临床肺科杂志, 2019, 24(11):2075-2078. DOI: 10.3969/j.issn.1009-6663.2019.11.031.
ZHONG Y, MENG LF, YANG XH, et al, Progress on the application of immunosuppressant in lung transplantation[J]. J Clin Pulm Med, 2019, 24(11):2075-2078. DOI: 10.3969/j.issn.1009-6663.2019.11.031.
|
[17] |
SHTRAICHMAN O, AHYA VN. Malignancy after lung transplantation[J]. Ann Transl Med, 2020, 8(6):416. DOI: 10.21037/atm.2020.02.126.
|
[18] |
ZAFFIRI L, LONG A, NEELY ML, et al. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: analysis of ISHLT registry[J]. J Heart Lung Transplant, 2020, 39(10):1089-1099. DOI: 10.1016/j.healun.2020.06.010.
|
[19] |
CHAMBERS DC, CHERIKH WS, HARHAY MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10):1042-1055. DOI: 10.1016/j.healun.2019.08.001.
|
[20] |
COIFFARD B, PELARDY M, GOMEZ C, et al. Kinetics of peripheral blood lymphocyte subsets in lung transplant recipients[J]. J Heart Lung Transplant, 2015, 34(4):S260. DOI: 10.1016/j.healun.2015.01.724.
|
[21] |
COIFFARD B, PELARDY M, LOUNDOU AD, et al. Effect of immunosuppression on target blood immune cells within 1 year after lung transplantation: influence of age on T lymphocytes[J]. Ann Transplant, 2018, 23:11-24. DOI: 10.12659/aot.906372.
|
[22] |
NOSOTTI M, TARSIA P, MORLACCHI LC. Infections after lung transplantation[J]. J Thorac Dis, 2018, 10(6):3849-3868. DOI: 10.21037/jtd.2018.05.204.
|
[23] |
HODGE G, HODGE S, YEO A, et al. BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-like, and NK cells in the small airways[J]. Transplantation, 2017, 101(10):2469-2476. DOI: 10.1097/TP.0000000000001592.
|
[24] |
HARPER SJ, ALI JM, WLODEK E, et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection[J]. Proc Natl Acad Sci U S A, 2015, 112(41):12788-12793. DOI: 10.1073/pnas.1513533112.
|
[25] |
YAP M, BROUARD S, PECQUEUR C, et al. Targeting CD8 T-cell metabolism in transplantation[J]. Front Immunol, 2015, 6:547. DOI: 10.3389/fimmu.2015.00547.
|
[26] |
COIFFARD B, PILONI D, BOUCEKINE M, et al. Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: a multicenter international study[J]. Transpl Immunol, 2018, 48:47-54. DOI: 10.1016/j.trim.2018.02.013.
|
[27] |
GAUTHIER JM, LI W, HSIAO HM, et al. Mechanisms of graft rejection and immune regulation after lung transplant[J]. Ann Am Thorac Soc, 2017, 14(Suppl 3):S216-S219. DOI: 10.1513/AnnalsATS.201607-576MG.
|
[28] |
AHYA VN, DIAMOND JM. Lung transplantation[J]. Med Clin North Am, 2019, 103(3):425-433. DOI: 10.1016/j.mcna.2018.12.003.
|
[29] |
YOUNG KA, DILLING DF. The future of lung transplantation[J]. Chest, 2019, 155(3):465-473. DOI: 10.1016/j.chest.2018.08.1036.
|
[30] |
HACHEM RR. Acute rejection and antibody-mediated rejection in lung transplantation[J]. Clin Chest Med, 2017, 38(4):667-675. DOI: 10.1016/j.ccm.2017.07.008.
|